Report #2898183

Received May 28, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: NE
Recovered: Unknown
Vaccinated: May 11, 2026
Onset: May 11, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
MNQ	MENINGOCOCCAL CONJUGATE (MENVEO)	NOVARTIS VACCINES AND DIAGNOSTICS	2	AMVBO64A	—

Symptoms (1)

Expired product administered

Symptom narrative

expired dose administered to a patient; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a patient who received Men ACWY-CRM NVS (Menveo) solution for injection (batch number AMVBO64A with expiry date 31-DEC-2025) for prophylaxis. Previously administered products included Menveo (received first dose on an unknown date). On 11-MAY-2026, the patient received the 2nd dose of Menveo. On 11-MAY-2026, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: expired dose administered to a patient).The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date:21-MAY-2026 The patient was administered an expired dose of Menveo 2-vial as the second dose of the series.